Valuation: Crossject

Market Cap 73.17M 81.59M 67.44M 61.24M 116M 7.65B 119M 807M 322M 4.1B 306M 300M 12.96B P/E 2026 *
3.28x
P/E 2027 * 2.58x
Enterprise Value 55.27M 61.63M 50.94M 46.26M 87.55M 5.78B 90M 610M 243M 3.1B 231M 226M 9.79B EV / Sales 2026 *
0.91x
EV / Sales 2027 * 0.4x
Free-Float
81.08%
Yield 2026 *
-
Yield 2027 * -
1 day+6.67%
1 week+7.52%
Current month+6.33%
1 month+1.82%
3 months-10.28%
6 months-29.63%
Current year-38.63%
1 week 1.19
Extreme 1.19
1.35
1 month 1.1
Extreme 1.1
1.36
Current year 1.1
Extreme 1.1
2.58
1 year 1.1
Extreme 1.1
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
6.84
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
7/4/25 A Buy

Director

13,386 0.0266%
7/1/25 A Buy

Director

50 0.0001%
7/1/25 A Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+6.67%+7.52%-39.87%-69.70% 76.85M
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 126B
-0.44%+4.42%-8.66%+18.52% 124B
-1.57%+0.37%-39.17%+6.93% 98.14B
+0.85%+2.41%-4.37%+76.50% 65.98B
-1.23%+7.29%+17.05%-9.39% 58.63B
-1.42%+3.66%-1.82%+62.49% 55.67B
+0.91%-2.81%-5.08%+55.00% 48.78B
+1.08%+2.42%+4.85%-6.69% 36.03B
Average +0.36%+2.21%-7.97%+19.49% 80B
Weighted average by Cap. -0.47%+2.53%-6.86%+27.66%

Financials

2026 *2027 *
Net sales 60.8M 67.8M 56.03M 50.89M 96.31M 6.36B 99M 671M 267M 3.41B 254M 249M 10.77B 65.2M 72.7M 60.09M 54.57M 103M 6.82B 106M 719M 287M 3.65B 273M 267M 11.55B
Net income 6.6M 7.36M 6.08M 5.52M 10.45M 690M 10.75M 72.83M 29.02M 370M 27.62M 27.03M 1.17B 8.6M 9.59M 7.93M 7.2M 13.62M 899M 14M 94.9M 37.81M 482M 35.99M 35.23M 1.52B
Net Debt -17.9M -19.96M -16.5M -14.98M -28.35M -1.87B -29.15M -198M -78.7M -1B -74.91M -73.32M -3.17B -47M -52.41M -43.32M -39.34M -74.45M -4.91B -76.53M -519M -207M -2.63B -197M -193M -8.32B
Projected Income Statement - Annual - Crossject
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
10/11/26 €1.344 +6.67% 286,334
09/11/26 €1.260 +2.27% 121,250
06/11/26 €1.232 +1.48% 252,334
05/11/26 €1.214 -0.16% 156,812
04/11/26 €1.216 +1.50% 100,891
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Crossject
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.344EUR
Average target price
4.150EUR
Spread / Average Target
+208.78%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Crossject
  1. Stock Market
  2. Stocks
  3. ALCJ Stock